Publications by authors named "Aeshah A AlAzmi"

Claim this Profile
T
The Characteristics and Follow-Up of SARS-CoV-2 Infection in Pediatric Oncology Patients.
Raghad Alkharouby, Noura Aljehani, Nasser Alsubaie, Anas Alqarni, Mohammed Hariri, Aeshah A AlAzmi

Cureus· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Single-Center Study of Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Children With Tumor Lysis Syndrome.
Sawsan M Al Blewi, Aeshah A AlAzmi, Nagla Elimam, Wasil Jastaniah, Abdullah Mohammedkhalil

Cureus· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of handling, storage, and disposal practices of oral anticancer medications among cancer patients and their caregivers at home setting in the Princess Noorah Oncology Center.
Ashwag A Algethami, Majed A Alshamrani, Atika M AlHarbi, Aeshah A AlAzmi, Mansoor A Khan

J Oncol Pharm Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coping with the residency program during COVID-19: Hematology oncology pharmacy residents' perspective.
Aeshah A AlAzmi, Fouad AlNajjar, Majed AlShomrani

J Oncol Pharm Pract· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Cancer Treatment Shortages in Saudi Arabia: Results of a National Survey and Expert Panel Recommendations.
Aeshah A AlAzmi, Wasil Jastaniah, Hani S Alhamdan, Arwa O AlYamani, Waleed I AlKhudhyr

JCO Glob Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.
Omima Mustafa, Khalid Abdalla, Aeshah A AlAzmi, Naglla Elimam, Mohammed Burhan Abrar

J Oncol Pharm Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.
Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A AlAzmi, Amal Algamal

Hematology· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the e-prescribing system on the incidence and nature of drug-related problems in children in a Saudi hospital.
Aeshah A AlAzmi, Hani AlHamdan, Omaima Ahmed, Stephen Tomlin, Asia N Rashed

Int J Pharm Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia.
Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A AlAzmi, Aml M Elgaml

Exp Hematol Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia.
Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A AlAzmi, Mohammed Aseeri

Leuk Res Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis